Radius Health, Inc. announced the appointment of Al Medwar to the role of Senior Vice President of Business and Corporate Development, reporting to the Company's Chief Executive Officer, Scott Briggs. Mr. Medwar, an accomplished pharmaceutical executive with over thirty years of pharmaceutical industry experience, will lead business and strategy development in efforts to expand the Radius product portfolio and build upon the growth of TYMLOS for osteoporosis. Mr. Medwar brings significant business development experience which includes numerous in and out-licensing transactions to support growth-oriented commercial stage and biotech companies.

Prior to joining Radius, Mr. Medwar most recently served as Senior Vice President of Investor Relations and Corporate Communications and a member of the executive team at 9 Meters Biopharma, Inc., where he was responsible for investor and public relations and played a significant role in supporting strategic and business development efforts. Mr. Medwar also previously served as Executive Vice President of Corporate and Business Development at BioDelivery Sciences where he played an integral role over twelve years in numerous successful business development and financing transactions through the transition of the company from a development stage to a commercial entity with multiple marketed products. Mr. Medwar began his career in sales and marketing for Glaxo Wellcome.

He received a BA from Cornell University and his MBA from Bentley University Graduate School of Business.